The latest research progress of novel coronavirus "Omicron sub-variant BA.5"
Journal of Hainan Medical University
; 28(20):1-5, 2022.
Article
in English
| GIM | ID: covidwho-2320288
ABSTRACT
Since the outbreak of COVID-19, severe acute respiratory syndrome coronavirus 2 genome is still mutating, forming a variety of variants with strong transmission capacity, causing the spread of the epidemic worldwide, posing a serious threat to people's physical and mental health, and posing a major challenge to global public health. Omicron remains the main variant in several outbreaks worldwide, accounting for about 99% of the global genetic sequence. Recently, the World Health Organization announced that the subvariant of Omicron BA.5 has been found in more than 100 countries and regions around the world, causing the global epidemic rebound. However, there are few studies on the subvariant BA.5. This article reviews the latest research progress in epidemiology, infectivity, pathogenicity, vaccine and monoclonal antibody protection against Omicron subvariant BA.5, in order to provide reference for scientific prevention and control of Omicron subvariant BA.5.
human diseases; coronavirus disease 2019; viral diseases; genetic variation; pandemics; literature reviews; outbreaks; disease transmission; mental health; Who; epidemics; pathogenicity; infectivity; epidemiology; monoclonal antibodies; immunity; disease prevention; disease control; man; Severe acute respiratory syndrome coronavirus 2; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; SARS-CoV-2; viral infections; genetic variability; genotypic variability; genotypic variation; World Health Organization
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Topics:
Variants
Language:
English
Journal:
Journal of Hainan Medical University
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS